Long Non-coding RNAs and their Role in Metastasis

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Long non-coding RNAs (lncRNAs) were once dismissed as transcriptional noise but are now recognized for vital physiological roles.
• A significant body of evidence implicates lncRNAs in all stages of carcinogenesis and metastasis.
• The precise functions and mechanisms of action for most lncRNAs remain largely unelucidated.

Purpose of the Study:

• To review the critical role of lncRNAs in cancer metastasis.
• To categorize lncRNAs based on their in vitro and in vivo mechanisms of action and clinical relevance in metastasis.
• To discuss the translational potential of lncRNAs in cancer metastasis.

Main Methods:

• Literature review focusing on lncRNAs involved in cancer metastasis.
• Categorization of lncRNAs into three groups based on mode of action (in vitro/in vivo) and clinical significance.
• Analysis of studies detailing lncRNA involvement in carcinogenesis and metastasis.

Main Results:

• lncRNAs are classified into three categories based on their metastasis-related functions and validation levels.
• Category I includes lncRNAs with established in vitro, in vivo, and clinical data in metastasis (e.g., HOTAIR, H19, MALAT1).
• Category II comprises lncRNAs with in vitro and clinical data, but limited in vivo evidence (e.g., MEG3, ANRIL).
• Category III covers lncRNAs with partially resolved mechanisms and varying clinical validation in metastasis (e.g., BANCR, LIMT).

Conclusions:

• lncRNAs play multifaceted roles in cancer metastasis, acting through diverse mechanisms.
• Understanding lncRNA functions and classification is crucial for developing targeted cancer therapies.
• Further research into lncRNA mechanisms and clinical validation is essential for their translational application in oncology.